NCT05999136

Brief Summary

The goal of this clinical trial is to investigate the effects of replacing red meat with pulses, on cardiometabolic health and gut microbiome in individuals with unhealthy habits and sedentary lifestyles at high risk for cardiovascular diseases. The main questions it aims to answer are:

  • be assigned to either the Pulses Diet (PulD) group or the Plant Proteins Diet (PPD) group or the Habitual diet (HabD) group;
  • follow their habitual diet (HabD) or the prescribed dietary plan designed on individual habitual diet to be isocaloric and isoprotein but replacing red meat with pulses (PulD group) or a combination of pulses and plant-based meat substitutes (PPD group);
  • keep their physical activity levels unchanged during the entire intervention period;
  • be required to complete 7-day food diaries and associated questionnaires on appetite, along with additional questionnaires related to physical activity levels, overall well-being, mood, sleep quality, stool frequency and consistency at each nutritional intervention time-point. Researchers will compare PulD, PPD, and HabD to assess if the dietary interventions have an impact on cardiometabolic health and gut microbiome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 21, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

January 10, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2024

Completed
Last Updated

January 12, 2024

Status Verified

January 1, 2024

Enrollment Period

9 months

First QC Date

August 13, 2023

Last Update Submit

January 10, 2024

Conditions

Keywords

Gut microbiomeLegumesPulsesPlant proteinsCardiovascular diseasesRed meat substitutionProtein transitionOverweightObesity

Outcome Measures

Primary Outcomes (2)

  • Changes in fasting total cholesterol concentration

    Measure of serum total cholesterol concentration (mg/dL serum)

    2 months

  • Changes in plasma TMAO concentration

    Measure of plasma TMAO concentration (μmol/L plasma)

    2 months

Secondary Outcomes (43)

  • Changes in faecal microbiome

    2 months

  • Changes in urinary TMAO concentration

    2 months

  • Changes in urinary polyphenols concentration

    2 months

  • Changes in urinary urolithin concentration

    2 months

  • Changes in urinary betaine concentration

    2 months

  • +38 more secondary outcomes

Study Arms (3)

Pulses Diet (PulD)

EXPERIMENTAL

Subjects will follow a Pulses-enriched diet for 2 months.

Other: Pulses diet

Plant Proteins Diet (PPD)

EXPERIMENTAL

Subjects will follow a Plant protein-enriched diet for 2 months.

Other: Plant proteins diet

Habitual Diet (HabD)

ACTIVE COMPARATOR

Subjects will follow a habitual diet for two months.

Other: Habitual diet

Interventions

Subjects in the PulD group will be assigned a personalized diet prepared based on their own eating habits as established by 7-day food diary recalls. Energy values of habitual diets will be kept unchanged during the PulD intervention. The diet will be characterized by isocaloric and isoprotein substitutions, replacing habitual servings of red meat or processed meat with servings of pulses.

Pulses Diet (PulD)

Subjects in the PPD group will be assigned a personalized diet prepared based on their own eating habits as established by 7-day food diary recalls. Energy values of habitual diets will be kept unchanged during the PPD intervention. The diet will be characterized by isocaloric and isoprotein substitutions, replacing habitual servings of red meat or processed meat with a mixture of pulses and plant-based meat substitutes.

Plant Proteins Diet (PPD)

Control subjects will not change their habitual diet during intervention. All subjects will be requested not to change physical activity levels during the 8 week intervention period.

Habitual Diet (HabD)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • men and women aged 18-65;
  • ≤ BMI ≤ 35 kg/m2;
  • habitual diet characterized by ≥ 3 medium servings of fresh red meat or processed meat (equivalent to a portion weight of 100g of fresh meat and 50g of cured meats);
  • habitual diet without probiotics, functional foods, and/or any type of food supplements;
  • low level of physical activity (sedentary lifestyle);
  • signing the informed consent form and expressing consent for the processing of personal data.

You may not qualify if:

  • Food allergies and intolerances, such as celiac disease, lactose intolerance, and others;
  • Gastrointestinal disorders of any kind;
  • Significant medical conditions;
  • Pregnancy or breastfeeding;
  • Hypertriglyceridemia (Triglycerides \> 200 mg/dL);
  • Hypercholesterolemia (Cholesterol \> 200 mg/dL);
  • Diabetes (Blood glucose ≥ 126 mg/dL);
  • Hypertension (Blood pressure \> 140/90 mm Hg);
  • Weight loss ≥ 3 kg in the past 2 months prior to the study;
  • Use of any medication at enrollment and in the 2 months prior to the study;
  • Regular diet rich in fruits and vegetables;
  • Consumption of alcohol equivalent to or exceeding 3 glasses of wine per day;
  • Concurrent participation in other clinical trials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Agricultural Sciences, Federico II University

Portici, 80055, Italy

RECRUITING

Related Publications (2)

  • Crimarco A, Springfield S, Petlura C, Streaty T, Cunanan K, Lee J, Fielding-Singh P, Carter MM, Topf MA, Wastyk HC, Sonnenburg ED, Sonnenburg JL, Gardner CD. A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: Study With Appetizing Plantfood-Meat Eating Alternative Trial (SWAP-MEAT). Am J Clin Nutr. 2020 Nov 11;112(5):1188-1199. doi: 10.1093/ajcn/nqaa203.

  • Meslier V, Laiola M, Roager HM, De Filippis F, Roume H, Quinquis B, Giacco R, Mennella I, Ferracane R, Pons N, Pasolli E, Rivellese A, Dragsted LO, Vitaglione P, Ehrlich SD, Ercolini D. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut. 2020 Jul;69(7):1258-1268. doi: 10.1136/gutjnl-2019-320438. Epub 2020 Feb 19.

MeSH Terms

Conditions

Mental DisordersCardiovascular DiseasesOverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Paola Vitaglione, Professor

    Department of Agricultural Sciences, Federico II University

    STUDY DIRECTOR

Central Study Contacts

Paola Vitaglione, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

August 13, 2023

First Posted

August 21, 2023

Study Start

January 10, 2024

Primary Completion

October 16, 2024

Study Completion

October 16, 2024

Last Updated

January 12, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

All individual participant data that underlie the results reported in the publication will be shared after deidentification

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data will become available immediately after the publications of the results with no end date.
Access Criteria
Metagenomic reads generated in this study will be available (without conditions of reuse) at the European Nucleotide Archive (ENA) in European Bioinformatics Institute (EBI), by using a specific accession number. The clinical data will be shared with any researcher who will ask the corresponding author by providing a methodologically sound proposal.

Locations